- Home
- NGNE vs BACQ Comparison
NGNE vs BACQ Comparison
Compare NGNE & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- BACQ
- Stock Information
- Founded
- NGNE 2003
- BACQ 2024
- Country
- NGNE United States
- BACQ United States
- Employees
- NGNE N/A
- BACQ N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- BACQ
- Sector
- NGNE Health Care
- BACQ
- Exchange
- NGNE Nasdaq
- BACQ NYSE
- Market Cap
- NGNE 352.4M
- BACQ 333.2M
- IPO Year
- NGNE N/A
- BACQ 2024
- Fundamental
- Price
- NGNE $16.62
- BACQ $9.91
- Analyst Decision
- NGNE Strong Buy
- BACQ
- Analyst Count
- NGNE 6
- BACQ 0
- Target Price
- NGNE $60.80
- BACQ N/A
- AVG Volume (30 Days)
- NGNE 223.3K
- BACQ 2.3K
- Earning Date
- NGNE 11-18-2024
- BACQ 01-01-0001
- Dividend Yield
- NGNE N/A
- BACQ N/A
- EPS Growth
- NGNE N/A
- BACQ N/A
- EPS
- NGNE N/A
- BACQ N/A
- Revenue
- NGNE $925,000.00
- BACQ N/A
- Revenue This Year
- NGNE N/A
- BACQ N/A
- Revenue Next Year
- NGNE N/A
- BACQ N/A
- P/E Ratio
- NGNE N/A
- BACQ N/A
- Revenue Growth
- NGNE N/A
- BACQ N/A
- 52 Week Low
- NGNE $14.44
- BACQ N/A
- 52 Week High
- NGNE $74.49
- BACQ N/A
- Technical
- Relative Strength Index (RSI)
- NGNE 29.82
- BACQ N/A
- Support Level
- NGNE $17.63
- BACQ N/A
- Resistance Level
- NGNE $20.29
- BACQ N/A
- Average True Range (ATR)
- NGNE 1.49
- BACQ 0.00
- MACD
- NGNE -0.17
- BACQ 0.00
- Stochastic Oscillator
- NGNE 7.29
- BACQ 0.00
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About BACQ BLEICHROEDER ACQUISITION CORP. I
Bleichroeder Acquisition Corp I is a blank check company.